Trial Outcomes & Findings for A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists (NCT NCT05335369)
NCT ID: NCT05335369
Last Updated: 2026-05-11
Results Overview
A 9-item Shared Decision Making questionnaire (SDM-Q-9) assessing patient satisfaction with the medical decision-making process. Scores are transformed to a 0-100 scale in accordance with measure guidelines, with higher scores indicating greater shared decision making between the patient and the provider.
COMPLETED
NA
161 participants
Within 1-4 weeks after treatment initiation
2026-05-11
Participant Flow
Patients aged 60 and above with AML were recruited from June 2022 to July 2025. Patients were recruited from 1) the Wilmot Cancer Institute inpatient malignant hematology service and 2) hematology clinics at Wilmot Cancer Institute. Enrolled patients could enroll with a caregiver, but were not required to. Oncologists at the Wilmot Cancer Institute were eligible if they treated at least one enrolled patient.
Participant milestones
| Measure |
Patient: UR-GOAL Intervention
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.
|
Patient: Usual Care Control
Usual care
|
Caregiver: UR-GOAL Intervention
Patients had the option to enroll with a caregiver. Caregivers were assigned to the same study arm as the patient with whom they enrolled. Before the AML treatment decision was made, caregivers in the UR-GOAL Intervention arm were provided with the same summary report and AML educational video as the patients.
|
Caregiver: Usual Care Control
Patients had the option to enroll with a caregiver. Caregivers were assigned to the same study arm as the patient with whom they enrolled. Caregivers in the Usual Care Control were not provided with additional information beyond usual care.
|
Oncologist
Oncologists treated patients who were allocated to either study arm. For patients in the UR-GOAL Intervention arm, the oncologist received a summary report containing the patient's treatment preferences, fitness level, and prognostic awareness. Oncologists did not receive this report for patients allocated to the Usual Care Control arm. Oncologists provided both data about themselves (for example, demographics) and data about the enrolled patients they treated (for example, disease understanding).
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
50
|
50
|
25
|
28
|
8
|
|
Overall Study
COMPLETED
|
43
|
38
|
20
|
25
|
8
|
|
Overall Study
NOT COMPLETED
|
7
|
12
|
5
|
3
|
0
|
Reasons for withdrawal
| Measure |
Patient: UR-GOAL Intervention
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.
|
Patient: Usual Care Control
Usual care
|
Caregiver: UR-GOAL Intervention
Patients had the option to enroll with a caregiver. Caregivers were assigned to the same study arm as the patient with whom they enrolled. Before the AML treatment decision was made, caregivers in the UR-GOAL Intervention arm were provided with the same summary report and AML educational video as the patients.
|
Caregiver: Usual Care Control
Patients had the option to enroll with a caregiver. Caregivers were assigned to the same study arm as the patient with whom they enrolled. Caregivers in the Usual Care Control were not provided with additional information beyond usual care.
|
Oncologist
Oncologists treated patients who were allocated to either study arm. For patients in the UR-GOAL Intervention arm, the oncologist received a summary report containing the patient's treatment preferences, fitness level, and prognostic awareness. Oncologists did not receive this report for patients allocated to the Usual Care Control arm. Oncologists provided both data about themselves (for example, demographics) and data about the enrolled patients they treated (for example, disease understanding).
|
|---|---|---|---|---|---|
|
Overall Study
Death
|
4
|
3
|
0
|
0
|
0
|
|
Overall Study
Withdrawal by Subject
|
2
|
6
|
3
|
3
|
0
|
|
Overall Study
Went to hospice
|
1
|
3
|
0
|
0
|
0
|
|
Overall Study
Lost to Follow-up
|
0
|
0
|
2
|
0
|
0
|
Baseline Characteristics
One oncologist declined to provide their year of birth
Baseline characteristics by cohort
| Measure |
Caregiver: Usual Care Control
n=28 Participants
Patients had the option to enroll with a caregiver. Caregivers were assigned to the same study arm as the patient with whom they enrolled. Caregivers in the Usual Care Control were not provided with additional information beyond usual care.
|
Caregiver: UR-GOAL Intervention
n=25 Participants
Patients had the option to enroll with a caregiver. Caregivers were assigned to the same study arm as the patient with whom they enrolled. Before the AML treatment decision was made, caregivers in the UR-GOAL Intervention arm were provided with the same summary report and AML educational video as the patients.
|
Patient: UR-GOAL Intervention
n=50 Participants
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.
|
Patient: Usual Care Control
n=50 Participants
Usual care
|
Oncologist
n=8 Participants
Oncologists treated patients who were allocated to either study arm. For patients in the UR-GOAL Intervention arm, the oncologist received a summary report containing the patient's treatment preferences, fitness level, and prognostic awareness. Oncologists did not receive this report for patients allocated to the Usual Care Control arm. Oncologists provided both data about themselves (for example, demographics) and data about the enrolled patients they treated (for example, disease understanding).
|
Total
n=161 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Continuous
|
62.3 Years
STANDARD_DEVIATION 17.7 • n=28 Participants • One oncologist declined to provide their year of birth
|
62.2 Years
STANDARD_DEVIATION 13.8 • n=25 Participants • One oncologist declined to provide their year of birth
|
74.0 Years
STANDARD_DEVIATION 8.3 • n=50 Participants • One oncologist declined to provide their year of birth
|
73.9 Years
STANDARD_DEVIATION 6.1 • n=50 Participants • One oncologist declined to provide their year of birth
|
41.3 Years
STANDARD_DEVIATION 12.2 • n=7 Participants • One oncologist declined to provide their year of birth
|
68.73 Years
STANDARD_DEVIATION 13.60 • n=160 Participants • One oncologist declined to provide their year of birth
|
|
Sex: Female, Male
Female
|
21 Participants
n=28 Participants
|
16 Participants
n=25 Participants
|
22 Participants
n=50 Participants
|
17 Participants
n=50 Participants
|
4 Participants
n=8 Participants
|
80 Participants
n=161 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=28 Participants
|
9 Participants
n=25 Participants
|
28 Participants
n=50 Participants
|
33 Participants
n=50 Participants
|
4 Participants
n=8 Participants
|
81 Participants
n=161 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=28 Participants
|
0 Participants
n=25 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=161 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=28 Participants
|
0 Participants
n=25 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=50 Participants
|
1 Participants
n=8 Participants
|
1 Participants
n=161 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=28 Participants
|
0 Participants
n=25 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=161 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=28 Participants
|
0 Participants
n=25 Participants
|
4 Participants
n=50 Participants
|
2 Participants
n=50 Participants
|
0 Participants
n=8 Participants
|
8 Participants
n=161 Participants
|
|
Race (NIH/OMB)
White
|
26 Participants
n=28 Participants
|
25 Participants
n=25 Participants
|
45 Participants
n=50 Participants
|
48 Participants
n=50 Participants
|
7 Participants
n=8 Participants
|
151 Participants
n=161 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=28 Participants
|
0 Participants
n=25 Participants
|
1 Participants
n=50 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=8 Participants
|
1 Participants
n=161 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=28 Participants
|
0 Participants
n=25 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=50 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=161 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=28 Participants
|
1 Participants
n=25 Participants
|
2 Participants
n=50 Participants
|
1 Participants
n=50 Participants
|
0 Participants
n=8 Participants
|
4 Participants
n=161 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
26 Participants
n=28 Participants
|
22 Participants
n=25 Participants
|
45 Participants
n=50 Participants
|
48 Participants
n=50 Participants
|
8 Participants
n=8 Participants
|
149 Participants
n=161 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=28 Participants
|
2 Participants
n=25 Participants
|
3 Participants
n=50 Participants
|
1 Participants
n=50 Participants
|
0 Participants
n=8 Participants
|
8 Participants
n=161 Participants
|
|
Marital Status
Divorced, Single, or Widowed
|
5 Participants
n=28 Participants • Oncologists did not report their marital status.
|
7 Participants
n=25 Participants • Oncologists did not report their marital status.
|
21 Participants
n=50 Participants • Oncologists did not report their marital status.
|
15 Participants
n=50 Participants • Oncologists did not report their marital status.
|
0 Participants
Oncologists did not report their marital status.
|
48 Participants
n=153 Participants • Oncologists did not report their marital status.
|
|
Marital Status
Married or Long-term partner
|
23 Participants
n=28 Participants • Oncologists did not report their marital status.
|
18 Participants
n=25 Participants • Oncologists did not report their marital status.
|
29 Participants
n=50 Participants • Oncologists did not report their marital status.
|
35 Participants
n=50 Participants • Oncologists did not report their marital status.
|
0 Participants
Oncologists did not report their marital status.
|
105 Participants
n=153 Participants • Oncologists did not report their marital status.
|
|
Education
High School or Below
|
7 Participants
n=28 Participants • Oncologists did not report their education.
|
5 Participants
n=25 Participants • Oncologists did not report their education.
|
15 Participants
n=50 Participants • Oncologists did not report their education.
|
17 Participants
n=50 Participants • Oncologists did not report their education.
|
0 Participants
Oncologists did not report their education.
|
44 Participants
n=153 Participants • Oncologists did not report their education.
|
|
Education
Some College/University
|
5 Participants
n=28 Participants • Oncologists did not report their education.
|
6 Participants
n=25 Participants • Oncologists did not report their education.
|
19 Participants
n=50 Participants • Oncologists did not report their education.
|
14 Participants
n=50 Participants • Oncologists did not report their education.
|
0 Participants
Oncologists did not report their education.
|
44 Participants
n=153 Participants • Oncologists did not report their education.
|
|
Education
College or Post-Graduate
|
16 Participants
n=28 Participants • Oncologists did not report their education.
|
14 Participants
n=25 Participants • Oncologists did not report their education.
|
16 Participants
n=50 Participants • Oncologists did not report their education.
|
19 Participants
n=50 Participants • Oncologists did not report their education.
|
0 Participants
Oncologists did not report their education.
|
65 Participants
n=153 Participants • Oncologists did not report their education.
|
|
Employment
Employed
|
10 Participants
n=28 Participants • Oncologists did not report their employment.
|
10 Participants
n=25 Participants • Oncologists did not report their employment.
|
8 Participants
n=50 Participants • Oncologists did not report their employment.
|
6 Participants
n=50 Participants • Oncologists did not report their employment.
|
0 Participants
Oncologists did not report their employment.
|
34 Participants
n=153 Participants • Oncologists did not report their employment.
|
|
Employment
Retired, Unemployed, Homemaker
|
17 Participants
n=28 Participants • Oncologists did not report their employment.
|
14 Participants
n=25 Participants • Oncologists did not report their employment.
|
42 Participants
n=50 Participants • Oncologists did not report their employment.
|
44 Participants
n=50 Participants • Oncologists did not report their employment.
|
0 Participants
Oncologists did not report their employment.
|
117 Participants
n=153 Participants • Oncologists did not report their employment.
|
|
Employment
Other
|
1 Participants
n=28 Participants • Oncologists did not report their employment.
|
1 Participants
n=25 Participants • Oncologists did not report their employment.
|
0 Participants
n=50 Participants • Oncologists did not report their employment.
|
0 Participants
n=50 Participants • Oncologists did not report their employment.
|
0 Participants
Oncologists did not report their employment.
|
2 Participants
n=153 Participants • Oncologists did not report their employment.
|
|
ECOG (KPS)
0 (90-100)
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
10 Participants
n=50 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
16 Participants
n=50 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
26 Participants
n=100 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
|
ECOG (KPS)
1 (70-80)
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
28 Participants
n=50 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
19 Participants
n=50 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
47 Participants
n=100 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
|
ECOG (KPS)
2 (50-60)
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
12 Participants
n=50 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
9 Participants
n=50 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
21 Participants
n=100 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
|
ECOG (KPS)
3 (30-40)
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
n=50 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
6 Participants
n=50 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
0 Participants
Oncologists and Caregivers did not report their ECOG (KPS).
|
6 Participants
n=100 Participants • Oncologists and Caregivers did not report their ECOG (KPS).
|
|
GDS-15
Not Impaired
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
40 Participants
n=50 Participants • Oncologists and Caregivers did not report their GDS-15.
|
38 Participants
n=50 Participants • Oncologists and Caregivers did not report their GDS-15.
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
78 Participants
n=100 Participants • Oncologists and Caregivers did not report their GDS-15.
|
|
Physical Function
Not Impaired
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
12 Participants
n=50 Participants • Oncologists and Caregivers did not report their Physical Function.
|
15 Participants
n=50 Participants • Oncologists and Caregivers did not report their Physical Function.
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
27 Participants
n=100 Participants • Oncologists and Caregivers did not report their Physical Function.
|
|
Physical Function
Impaired
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
37 Participants
n=50 Participants • Oncologists and Caregivers did not report their Physical Function.
|
32 Participants
n=50 Participants • Oncologists and Caregivers did not report their Physical Function.
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
69 Participants
n=100 Participants • Oncologists and Caregivers did not report their Physical Function.
|
|
Mini-Cog
Missing
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
1 Participants
n=50 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
2 Participants
n=50 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
3 Participants
n=100 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
|
Physical Function
Missing
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
1 Participants
n=50 Participants • Oncologists and Caregivers did not report their Physical Function.
|
3 Participants
n=50 Participants • Oncologists and Caregivers did not report their Physical Function.
|
0 Participants
Oncologists and Caregivers did not report their Physical Function.
|
4 Participants
n=100 Participants • Oncologists and Caregivers did not report their Physical Function.
|
|
Mini-Cog
Not Impaired
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
45 Participants
n=50 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
39 Participants
n=50 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
84 Participants
n=100 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
|
Mini-Cog
Impaired
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
4 Participants
n=50 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
9 Participants
n=50 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
0 Participants
Oncologists and Caregivers did not report their Mini-Cog.
|
13 Participants
n=100 Participants • Oncologists and Caregivers did not report their Mini-Cog.
|
|
GDS-15
Impaired
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
9 Participants
n=50 Participants • Oncologists and Caregivers did not report their GDS-15.
|
11 Participants
n=50 Participants • Oncologists and Caregivers did not report their GDS-15.
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
20 Participants
n=100 Participants • Oncologists and Caregivers did not report their GDS-15.
|
|
GDS-15
Missing
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
1 Participants
n=50 Participants • Oncologists and Caregivers did not report their GDS-15.
|
1 Participants
n=50 Participants • Oncologists and Caregivers did not report their GDS-15.
|
0 Participants
Oncologists and Caregivers did not report their GDS-15.
|
2 Participants
n=100 Participants • Oncologists and Caregivers did not report their GDS-15.
|
|
Nutrition
Not Impaired
|
0 Participants
Oncologists and Caregivers did not report their Nutrition.
|
0 Participants
Oncologists and Caregivers did not report their Nutrition.
|
40 Participants
n=50 Participants • Oncologists and Caregivers did not report their Nutrition.
|
42 Participants
n=50 Participants • Oncologists and Caregivers did not report their Nutrition.
|
0 Participants
Oncologists and Caregivers did not report their Nutrition.
|
82 Participants
n=100 Participants • Oncologists and Caregivers did not report their Nutrition.
|
|
Nutrition
Impaired
|
0 Participants
Oncologists and Caregivers did not report their Nutrition.
|
0 Participants
Oncologists and Caregivers did not report their Nutrition.
|
10 Participants
n=50 Participants • Oncologists and Caregivers did not report their Nutrition.
|
8 Participants
n=50 Participants • Oncologists and Caregivers did not report their Nutrition.
|
0 Participants
Oncologists and Caregivers did not report their Nutrition.
|
18 Participants
n=100 Participants • Oncologists and Caregivers did not report their Nutrition.
|
PRIMARY outcome
Timeframe: Within 1-4 weeks after treatment initiationPopulation: 5 patients who completed some of the post-intervention surveys did not complete the SDM-Q-9 form.
A 9-item Shared Decision Making questionnaire (SDM-Q-9) assessing patient satisfaction with the medical decision-making process. Scores are transformed to a 0-100 scale in accordance with measure guidelines, with higher scores indicating greater shared decision making between the patient and the provider.
Outcome measures
| Measure |
Patient: UR-GOAL Intervention
n=39 Participants
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.
|
Patient: Usual Care Control
n=37 Participants
Usual care
|
|---|---|---|
|
Shared Decision Making
|
85.98 Score on a Scale
Standard Deviation 12.25
|
86.55 Score on a Scale
Standard Deviation 14.04
|
SECONDARY outcome
Timeframe: Within 1-4 weeks after treatment initiationPopulation: Analysis populations vary across domains due to missing responses and "does not apply" selections for specific items. Participants were included in each domain analysis if sufficient data were available for that domain.
A 36-item questionnaire assessing patient-centered communication in six domains: exchanging information, making decisions, fostering healing relationships, enabling patient self-management, managing uncertainty, and responding to emotions. The overall score and scores in each domain range from 1-5, higher scores indicate better communication.
Outcome measures
| Measure |
Patient: UR-GOAL Intervention
n=43 Participants
UR-GOAL helps conducts assessments of fitness, elicits patient values via Best-Worst Scaling, and elicits preferences for prognostic information and assesses prognostic awareness. The tool also includes an AML educational video.
|
Patient: Usual Care Control
n=38 Participants
Usual care
|
|---|---|---|
|
Patient-Centered Communication in Cancer Care (PCC-Ca-36)
Overall
|
4.20 Score on a Scale
Standard Deviation 0.60
|
4.31 Score on a Scale
Standard Deviation 0.58
|
|
Patient-Centered Communication in Cancer Care (PCC-Ca-36)
Fostering Healthy Relationship Domain
|
4.45 Score on a Scale
Standard Deviation 0.52
|
4.58 Score on a Scale
Standard Deviation 0.45
|
|
Patient-Centered Communication in Cancer Care (PCC-Ca-36)
Making Decisions Domain
|
4.37 Score on a Scale
Standard Deviation 0.64
|
4.61 Score on a Scale
Standard Deviation 0.54
|
|
Patient-Centered Communication in Cancer Care (PCC-Ca-36)
Responding to Emotions Domain
|
3.99 Score on a Scale
Standard Deviation 0.91
|
4.26 Score on a Scale
Standard Deviation 0.80
|
|
Patient-Centered Communication in Cancer Care (PCC-Ca-36)
Exchanging Information Domain
|
4.43 Score on a Scale
Standard Deviation 0.57
|
4.49 Score on a Scale
Standard Deviation 0.62
|
|
Patient-Centered Communication in Cancer Care (PCC-Ca-36)
Enabling Patient Self-Management Domain
|
3.95 Score on a Scale
Standard Deviation 0.87
|
3.91 Score on a Scale
Standard Deviation 0.83
|
|
Patient-Centered Communication in Cancer Care (PCC-Ca-36)
Managing Uncertainty Domain
|
3.93 Score on a Scale
Standard Deviation 0.87
|
3.91 Score on a Scale
Standard Deviation 0.82
|
Adverse Events
Patient: UR-GOAL Intervention
Patient: Usual Care Control
Caregiver: UR-GOAL Intervention
Caregiver: Usual Care Control
Oncologist
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place